ReGARDD
The Regulatory Guidance for Academic Research of Drugs and Devices (ReGARDD) affiliates are comprised of regulatory affairs specialists and experts from several Institutions in the Southeast that receive funding from the NIH Clinical and Translational Science Awards (CTSA) Program. ReGARDD provides academic researchers with the regulatory tools and resources necessary to successfully navigate the pathway from discovery to clinical implementation of new drugs, biologics and medical devices.
Synonyms
Regulatory Guidance for Academic Research of Drugs and Devices
University Of North Carolina Chapel HillUniversity Of Miami School Of MedicineVirginia Commonwealth UniversityReGARDD provides academic researchers with the regulatory tools and resources necessary to successfully navigate the pathway from discovery to clinical implementation of new drugs, biologics and medical devices.
-
University Of North Carolina Chapel HillDuke UniversityWake Forest University Health SciencesMedical University Of South CarolinaUniversity Of Miami School Of MedicineVirginia Commonwealth UniversityReGARDD provides academic researchers with the regulatory tools and resources necessary to successfully navigate the pathway from discovery to clinical implementation of new drugs, biologics and medical devices. Investigational New Drug or Biologic Investigational Device Exemption Educational Videos ReGARDD Sponsored Events Who We Are The Regulatory Guidance for Academic Research of Drugs and
May 07, 2018Three North Carolina Clinical and Translational Science Awards (CTSA) Program hubs have collaborated to create a platform for sharing regulatory expertise and best practices. The Regulatory Guidance for Academic Research of Drugs and Devices (ReGARDD) Program provides researchers with regulatory guidance, education, and consultative support, to ultimately help them move promising products and
